| UniProt ID | GALE_HUMAN | |
|---|---|---|
| UniProt AC | Q14376 | |
| Protein Name | UDP-glucose 4-epimerase {ECO:0000303|PubMed:22654673} | |
| Gene Name | GALE {ECO:0000312|HGNC:HGNC:4116} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 348 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes two distinct but analogous reactions: the reversible epimerization of UDP-glucose to UDP-galactose and the reversible epimerization of UDP-N-acetylglucosamine to UDP-N-acetylgalactosamine. The reaction with UDP-Gal plays a critical role in the Leloir pathway of galactose catabolism in which galactose is converted to the glycolytic intermediate glucose 6-phosphate. It contributes to the catabolism of dietary galactose and enables the endogenous biosynthesis of both UDP-Gal and UDP-GalNAc when exogenous sources are limited. Both UDP-sugar interconversions are important in the synthesis of glycoproteins and glycolipids.. | |
| Protein Sequence | MAEKVLVTGGAGYIGSHTVLELLEAGYLPVVIDNFHNAFRGGGSLPESLRRVQELTGRSVEFEEMDILDQGALQRLFKKYSFMAVIHFAGLKAVGESVQKPLDYYRVNLTGTIQLLEIMKAHGVKNLVFSSSATVYGNPQYLPLDEAHPTGGCTNPYGKSKFFIEEMIRDLCQADKTWNAVLLRYFNPTGAHASGCIGEDPQGIPNNLMPYVSQVAIGRREALNVFGNDYDTEDGTGVRDYIHVVDLAKGHIAALRKLKEQCGCRIYNLGTGTGYSVLQMVQAMEKASGKKIPYKVVARREGDVAACYANPSLAQEELGWTAALGLDRMCEDLWRWQKQNPSGFGTQA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 26 | Ubiquitination | VLELLEAGYLPVVID HHHHHHCCCCCEEEE | 18.35 | 21890473 | |
| 44 | Phosphorylation | NAFRGGGSLPESLRR HHHCCCCCCCHHHHH | 43.98 | 24719451 | |
| 65 | Sulfoxidation | RSVEFEEMDILDQGA CCCCHHHHCCCCHHH | 2.82 | 30846556 | |
| 80 | Phosphorylation | LQRLFKKYSFMAVIH HHHHHHHHCHHHHHH | 14.02 | 24719451 | |
| 81 | Phosphorylation | QRLFKKYSFMAVIHF HHHHHHHCHHHHHHH | 19.88 | 24719451 | |
| 97 | Phosphorylation | GLKAVGESVQKPLDY CHHHHHHHCCCCCCE | 24.74 | 24719451 | |
| 100 | Ubiquitination | AVGESVQKPLDYYRV HHHHHCCCCCCEEEE | 45.45 | 21890473 | |
| 100 | Ubiquitination | AVGESVQKPLDYYRV HHHHHCCCCCCEEEE | 45.45 | 21890473 | |
| 100 | Acetylation | AVGESVQKPLDYYRV HHHHHCCCCCCEEEE | 45.45 | 23236377 | |
| 104 | Phosphorylation | SVQKPLDYYRVNLTG HCCCCCCEEEECCCC | 10.80 | 20068231 | |
| 120 | Ubiquitination | IQLLEIMKAHGVKNL HHHHHHHHHCCCCEE | 42.78 | 21890473 | |
| 157 | Phosphorylation | TGGCTNPYGKSKFFI CCCCCCCCCCCHHHH | 38.98 | 20090780 | |
| 159 | Ubiquitination | GCTNPYGKSKFFIEE CCCCCCCCCHHHHHH | 44.63 | - | |
| 161 | Ubiquitination | TNPYGKSKFFIEEMI CCCCCCCHHHHHHHH | 48.02 | 21906983 | |
| 176 | Acetylation | RDLCQADKTWNAVLL HHHHHCCCCCCEEEH | 59.46 | 25953088 | |
| 176 | Ubiquitination | RDLCQADKTWNAVLL HHHHHCCCCCCEEEH | 59.46 | - | |
| 230 | Phosphorylation | LNVFGNDYDTEDGTG HHHHCCCCCCCCCCC | 28.85 | 27642862 | |
| 232 | Phosphorylation | VFGNDYDTEDGTGVR HHCCCCCCCCCCCCC | 29.73 | - | |
| 249 | Ubiquitination | IHVVDLAKGHIAALR EEEEHHHHHHHHHHH | 59.32 | 21890473 | |
| 249 | Ubiquitination | IHVVDLAKGHIAALR EEEEHHHHHHHHHHH | 59.32 | 21906983 | |
| 259 | Ubiquitination | IAALRKLKEQCGCRI HHHHHHHHHHHCCEE | 49.09 | - | |
| 259 | 2-Hydroxyisobutyrylation | IAALRKLKEQCGCRI HHHHHHHHHHHCCEE | 49.09 | - | |
| 267 | Phosphorylation | EQCGCRIYNLGTGTG HHHCCEEEECCCCCC | 5.74 | 20068231 | |
| 271 | Phosphorylation | CRIYNLGTGTGYSVL CEEEECCCCCCHHHH | 34.43 | 20068231 | |
| 273 | Phosphorylation | IYNLGTGTGYSVLQM EEECCCCCCHHHHHH | 32.55 | 20068231 | |
| 275 | Phosphorylation | NLGTGTGYSVLQMVQ ECCCCCCHHHHHHHH | 8.74 | 20068231 | |
| 276 | Phosphorylation | LGTGTGYSVLQMVQA CCCCCCHHHHHHHHH | 20.07 | 20068231 | |
| 286 | Ubiquitination | QMVQAMEKASGKKIP HHHHHHHHHCCCCCC | 34.46 | 21890473 | |
| 295 | Ubiquitination | SGKKIPYKVVARREG CCCCCCCEEEECCCC | 25.52 | - | |
| 338 | Ubiquitination | EDLWRWQKQNPSGFG HHHHHHHHHCCCCCC | 45.12 | 2190698 | |
| 338 | Ubiquitination | EDLWRWQKQNPSGFG HHHHHHHHHCCCCCC | 45.12 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GALE_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GALE_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GALE_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| GALE_HUMAN | GALE | physical | 16189514 | |
| A4_HUMAN | APP | physical | 21832049 | |
| GALE_HUMAN | GALE | physical | 25416956 | |
| GALE_HUMAN | GALE | physical | 18188677 | |
| ACADM_HUMAN | ACADM | physical | 26344197 | |
| MTND_HUMAN | ADI1 | physical | 26344197 | |
| ARMC1_HUMAN | ARMC1 | physical | 26344197 | |
| ASNS_HUMAN | ASNS | physical | 26344197 | |
| CD2AP_HUMAN | CD2AP | physical | 26344197 | |
| ETFA_HUMAN | ETFA | physical | 26344197 | |
| GALK2_HUMAN | GALK2 | physical | 26344197 | |
| ITPA_HUMAN | ITPA | physical | 26344197 | |
| PAXI_HUMAN | PXN | physical | 26344197 | |
| WDR1_HUMAN | WDR1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 230350 | Epimerase-deficiency galactosemia (EDG) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...